An essay in PLoS Medicine lays out an aggressive strategy for attacking ghostwriting abuses: Make everyone — including writers and scientists who lend their names and reputations to the ghostwritten articles — legally liable for resulting patient injuries: "Although guest authors and pharmaceutical defendants may argue a First Amendment right to participate in ghostwriting, the U.S. Supreme Court has firmly held that the First Amendment does not shield fraud."
February 2, 2012